RecruitingNot ApplicableNCT06409325

Effectiveness of MST Versus ECT for Major Depressive Episode

Effectiveness of Magnetic Seizure Therapy Versus Electroconvulsive Therapy for Major Depressive Episode


Sponsor

Shanghai Mental Health Center

Enrollment

210 participants

Start Date

Aug 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Despite advancements in Magnetic Seizure Therapy (MST) and Electroconvulsive Therapy (ECT) for Major Depressive Disorder (MDD), there remains a need for further research to replicate clinical outcomes and understand the therapeutic targets of these treatments. This study aims to address these gaps through a double-blinded, randomized, non-inferiority investigation comparing the efficacy, tolerability, cognitive adverse effects, and neurophysiological biomarkers of MST and bilateral ECT in patients with MDD.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This trial compares two brain stimulation therapies — magnetic seizure therapy (MST) and electroconvulsive therapy (ECT) — for people with severe major depression. Both involve brief electrical or magnetic stimulation of the brain under anesthesia; this study examines which works better with fewer side effects. **You may be eligible if...** - You are 18 to 65 years old - You have a confirmed diagnosis of major depressive disorder (MDD) - Your depression is severe (Hamilton Rating Scale score of 18 or higher) - You are taking one stable antidepressant medication **You may NOT be eligible if...** - You have a history of certain neurological conditions (e.g., seizure disorder) - You have a pacemaker, metal implants, or other contraindications to brain stimulation - You have bipolar disorder or another primary psychiatric diagnosis - You are under 18 or over 65 Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMST

MST was delivered with NS 7000 (Wuhan Yiruide Medical Equipment New Technology Co., Ltd.) using a round coil (125-mm diameter) positioned on the vertex.

DEVICEECT

The bitemporal ECT procedure utilized the Thymatron System IV device (Somatics, USA).


Locations(1)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06409325


Related Trials